Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

Carlo Palmieri; Rob C Stein; Xinxue Liu; Emma Hudson; Hanna Nicholas; Hironobu Sasano; Fouzia Guestini; Chris Holcombe; Sophie Barrett; Laura Kenny; Sadie Reed; Adrian Lim; Larry Hayward; Sacha Howell; R Charles Coombes; IRIStrial participants

doi:10.1007/s10549-017-4539-3

Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients

Breast Cancer Res Treat. 2018 Jan;167(1):407. doi: 10.1007/s10549-017-4539-3.

Authors

Carlo Palmieri^{1

2

3}, Rob C Stein⁴, Xinxue Liu⁵, Emma Hudson⁵, Hanna Nicholas⁵, Hironobu Sasano⁶, Fouzia Guestini⁶, Chris Holcombe⁷, Sophie Barrett⁸, Laura Kenny⁵, Sadie Reed⁵, Adrian Lim⁹, Larry Hayward¹⁰, Sacha Howell¹¹, R Charles Coombes⁵; IRIStrial participants

Affiliations

¹ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. [email protected].
² Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK. [email protected].
³ Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK. [email protected].
⁴ NIHR University College London Hospitals Biomedical Research Centre, London, NW1 2PG, UK.
⁵ Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
⁶ Department of Pathology, Tohoku University School of Medicine, Sendai, Japan.
⁷ Breast Unit, The Linda McCartney Centre, Royal Liverpool University Hospital, Liverpool, L7 8XP, UK.
⁸ Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, UK.
⁹ Department of Radiology, Imperial College NHS Foundation Trust, London, W8 6RF, UK.
¹⁰ Edinburgh Cancer Centre, Western General Hospital, Edinburgh, EH4 2XU, UK.
¹¹ Department of Medical Oncology, The University of Manchester, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.

Abstract

In the original publication of the article, a part of acknowledgement section was missed out. The omitted acknowledgement is given below: 'The study was coordinated by the Imperial Clinical Trials Unit-Cancer, Imperial College London and Sponsored by Imperial College London. The Imperial Clinical Trials Unit receives funding from the National Institute for Health (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This study was supported by Imperial Experimental Cancer Medicine Centre and Cancer Research UK Imperial Centre'.

Publication types

Published Erratum

Grants and funding

13392/CRUK_/Cancer Research UK/United Kingdom